Europe’s orthopaedic implant industry being transformed by innovation, regulation, and price pressure
7 January 2021Candesic has been quoted in the Healthcare Business International. "As healthcare becomes ever more personalised it’s impacting specialised markets, such…UK’s private healthcare groups hope for virus bounce
6 January 2021Candesic's Dr Michelle Tempest has been quoted in the Financial Times. "The NHS remains keen to work with the private…
Opportunities to blow your mind
22 December 2020For all those wanting to beat the blues before Christmas and get some of Candesic’s clear thinking in these chaotic…Birth Beyond Borders
3 December 2020The patchwork of regulation governing IVF treatment in Europe could be seen as a significant barrier to IVF providers looking…Best Practices: Scaling in Healthtech
27 November 2020Candesic's Dr Michelle Tempest was the panelist at "Best Practices: Scaling in Healthtech", hosted by The Healthtech Exchange. Michelle has…Inspiring Leaders – Dr Michelle Tempest
26 November 2020Candesic's Dr Michelle Tempest has been featured as the inspiring leaders in an article published by the RSA Group. Michelle shares…Private equity targeting €1.2bn Mediq
18 November 2020Mediq, the Top European medicalised homecare player in 13 countries worth c. €1.2bn is up for sale. Candesic's Marc Kitten spoke…Personalised medicine: Personalised mental health services
18 November 2020Can personalised medicine be used in mental health services? Candesic's Dr Michelle Tempest shared her knowledge at a panel from the…Candesic & Children’s Services
4 November 2020Candesic's Dr Michelle Tempest speaks to the Financial Times about the need for investment interest in UK children's services. "Investors…Health Data & Covid-19
25 September 2020Health data has the potential to revolutionise care, and this has come to the fore during the pandemic.
